Literature DB >> 4162604

Horse anti-pneumococcal immunoglobulins. II. Specific mouse protective activity.

W C Hill, J B Robbins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4162604     DOI: 10.3181/00379727-123-31414

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  7 in total

1.  Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci.

Authors:  S C Szu; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

2.  The specific secondary biological activities of rabbit IgM and IgG anti-Salmonella typhimurium 'O' antibodies isolated during the development of the immune response.

Authors:  M L Schulkind; K Kenny; M Herzberg; J B Robbins
Journal:  Immunology       Date:  1972-08       Impact factor: 7.397

3.  Immunological paralysis of mice with pneumococcal polysaccharide antigens.

Authors:  W J Halliday
Journal:  Bacteriol Rev       Date:  1971-09

4.  A quantitative study of the transfer of colostral immunoglobulins to the newborn calf.

Authors:  G G Klaus; A Bennett; E W Jones
Journal:  Immunology       Date:  1969-03       Impact factor: 7.397

5.  Specific secondary biological properties of purified rabbit immunoglobulin M and immunoglobulin G antibodies to Brucella abortus and Bordetella pertussis.

Authors:  M L Schulkind; M Herzberg; J B Robbins
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

6.  Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharide.

Authors:  Tamika Burns; Zhaojing Zhong; Michael Steinitz; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

7.  Protective murine monoclonal antibodies to Cryptococcus neoformans.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.